Akso Health Group current report, Q4 FY2018

SEC Filing Summary: Hexindai Inc. (Form 6-K)

Business Context and Reporting Period

This Form 6-K is a report of a foreign private issuer filed by Hexindai Inc. for the month of November 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on November 19, 2018. Note: The input metadata references "Akso Health Group," but the filing text explicitly identifies the registrant as Hexindai Inc.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a cover sheet for a press release (Exhibit 99.1) and does not contain embedded financial tables or narrative financial data.

Material Changes

The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided text.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the form header, signature block, and an exhibit index.

Key Facts for Investor Verification

  • Verify the actual content of Exhibit 99.1 (Press Release) to obtain the specific news or financial data triggering this filing.
  • Confirm the discrepancy between the metadata company name ("Akso Health Group") and the registrant name in the filing ("Hexindai Inc.").
  • Note that this filing is a procedural report for November 2018 and does not contain standalone financial statements.